Hackpads are smart collaborative documents. Join Hackpad Now.

Jay Sharma

37 days ago
Unfiled. Edited by Jay Sharma 37 days ago
Next Generation   Sequencing Market Demand, Size, Share, Scope & Forecast To 2027
Jay S The global next generation sequencing market was valued at USD 5,793.4 million in 2019 and is expected to reach USD 22.16 billion by the year 2027, at a CAGR of 15.9%. Next-generation sequencing non-Sanger based high throughput method of sequencing. Entire next generation sequencing methodology engages a wide range of reagents, kits, equipment, software and tools for the pieces of its entire workflow that includes sample preparation, library preparation & amplification, sequencing, and analysis. Due to the constant innovations in the NGS technologies, there has been a significant decline in the sequencing costs, complexity and turnaround time. Horizons of the NGS applications is expanding, which in turn offers ample opportunities to emerging as well the existing market players.
Illumina, ThermoFisher Scientific, Pacific biosciences, and Oxford Nanopore Technologies are among key innovators of next generation sequencing technologies. Based on the application, individual technologies are conquering the NGS markets across the globe. Illumina’s SBS technology remains the top choice of the researchers across the globe, considering the reducing costs and high precision. Clinical Diagnostic applications of NGS is dominated by ThermoFisher’s semiconductor NGS technology owing it to its less turnaround time. Pacific Biosciences’ long read sequencing technology is paving its success path for the de-novo sequencing applications. Oxford Nanopore remains a key innovator with its long read, portable, real-time sequencing offerings. Despite differences in the technological basis of individual companies, the market players in NGS products & services are focused on providing low cost, efficient, reliable, user friendly, compact and accurate sequencing experience to their customers. Furthermore, bioinformatics tools plays a vital role in the advancement of NGS workflow and analysis, and continues to register significant growth in the global market. Also, NGS services holds more than one fourth of the revenue generated in the global next generation sequencing market and is fragmented in nature, unlike NGS products market.
Top Companies Profiled in the Report Include:
 Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Oxford Nanopore Technologies, Ltd. (U.K.), BGI (China), PerkinElmer (U.S.), Agilent Technologies (U.S.), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), and Eurofins Scientific (Luxembourg)
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Next Generation Sequencing market in these key regions.
Additionally, the report consists a detailed analysis of the segmentation of the Next Generation Sequencing market based on product types and end-use/application offered in the Next Generation Sequencing market.
Product & Service Outlook (Revenue in Million USD; 2017–2027)
Pre-sequencing Products and Services
Sample Preparation
Library Preparation & Target Enrichment
Quality Control
NGS Consumables
NGS Platforms
Illumina
Hiseq Series
Hiseq X Ten & HiSeq X Five
Miseq Series
NextSeq500
MiniSeq
NovaSeq
iSeq
Thermo Fisher Scientific
Ion PGM
Ion Proton
Ion Genestudio
Ion GeneStudio S5 System
Ion GeneStudio S5 Plus System
Ion GeneStudio S5 Prime System
Pacific Biosciences
Pacbio Sequel Systems
Oxford Nanopore Technologies
Other Next-generation Platforms
Services for NGS Platforms
Sequencing Services
Exome & Targeted Sequencing and Custom Panels
RNA-Seq
Whole-genome Sequencing and De Novo Sequencing
Other Services
Bioinformatics
NGS Data Analysis Software & Workbenches
NGS Data Analysis Services
NGS Storage Management and Cloud Computing Solutions
Technology Outlook (Revenue in Million USD; 2017–2027)
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing (SMRT)
Nanopore Sequencing
Other Technologies
Application Outlook (Revenue in Million USD; 2017–2027)
Diagnostics
Cancer Diagnostics
Infectious Disease Diagnostics
Reproductive Health Diagnostics
Other Diagnostic Applications
Drug Discovery
Agricultural and Animal Research
Other Applications
End User Outlook (Revenue in Million USD; 2017–2027)
Academia & Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users
  Country-wise regional analysis covers:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Read More Reports –
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.  
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:                       
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
 
36 days ago
Unfiled. Edited by Jay Sharma 36 days ago
Revenue, Statistics, Industry   Growth and Demand Analysis Research Report by 2028
 
Jay S The global dental lasers market size is expected to reach USD 345.1 million by 2028 at a CAGR of 5.5%, according to a new report by Reports and Data. The major market revenue growth driving factors are growing cases of dental disorders, rising geriatric population, surging awareness about oral hygiene, and growing preferences for minimally invasive dental surgeries. Rising adoption of laser dentistry, increasing applications of dental lasers in cosmetic dentistry, emergence of technologically advanced dental diagnostics, and increasing healthcare spending are other key factors accountable for the growth of the global dental lasers market in the near future.
Dental lasers are specific devices used in oral surgeries. These devices are highly suited for dental procedures and are increasingly replacing conventional dental surgical instruments like dental drills, dental anesthetics, and hand pieces. Dental lasers are comparatively safer and more efficient and are widely used in dental procedures such as hard tissue and soft tissue procedures. These devices find extensive application in various hard tissue procedures including cavity detection, tooth preparations and dental fillings, and treatment for tooth sensitivity, as well as soft tissue procedures such as crown lengthening, removal of soft tissue folds, teeth whitening, and treatment of gummy smiles and tongue frenulum attachment. Most dental lasers in commercial use are FDA-approved and are said to be more comfortable and cost-effective as compared to other non-laser tools. Moreover, these devices offer other significant advantages such as lower light exposure, reduced contamination, lesser bleeding, quicker healing time, and higher portability.
Top Companies Profiled in the Report Include:
Biolase Inc., AMD LASERS, FOTONA D.D., Convergent Dental, Ivoclar Vivadent AG, Danaher, Sirona, Syneron Dental, ZOLAR Technology & Mfg. Co. Inc., THE YOSHIDA DENTAL MFG. CO. LTD., and CAO Group Inc..
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Dental Lasers market in these key regions.
Country-wise regional analysis covers:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Additionally, the report consists a detailed analysis of the segmentation of the Dental Lasers market based on product types and end-use/application offered in the Dental Lasers market.
Product Type Outlook (Revenue, USD Billion; 2018-2028)
  • Diode lasers
  • Quantum well lasers
  • Distributed feedback lasers
  • Heterostructure lasers
  • Vertical cavity surface emitting lasers
  • Carbon dioxide lasers
  • Yttrium Aluminum Garnet Lasers
Application Outlook (Revenue, USD Billion; 2018-2028)
  • Conservative Dentistry
  • Endodontic treatment
  • Oral surgery
  • Implantology
  • Peri-implantitis
  • Periodontics
  • Tooth whitening
  • Others
End-Use Outlook (Revenue, USD Billion; 2018-2028)
  • Dental clinics
  • Hospitals
Read More Reports –
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
 
37 days ago
Unfiled. Edited by Jay Sharma 37 days ago
Urological Devices Market
 
Jay S The global urological devices market is forecast to reach USD 62.76 Billion by 2027, according to a new report by Reports and Data. The urological devices are all the equipment involved in the urological operations, diagnosis, treatment, analysis, testing, and others. Kidney diseases, bladder prolapse, urinary tract infections, erectile dysfunction, prostatitis, urologic oncology, and pediatric urology, to name a few, are some of the most common urological diseases that require the urological devices in the treatment system. Rising incidences of geriatric and pediatric urological disorders are few growing diseases that incorporate the urological devices in the procedures and treatments. Improving healthcare facilities in the developing regions are effectively helping in the market growth. An increased awareness about healthcare & wellness, changing urological disease patterns, government supports, and escalating volumes of urological healthcare services is expected to take part in the rapid growth of this market.
The North American market is forecasted to generate the highest revenue of USD 22.15 Billion in the year 2027, owing to its extensive demand for urology devices in the hospitals and ambulatory surgery centers. Asia Pacific, with its elevated growth in the healthcare industry and escalating volumes of urological patients in China, India, and Japan, is likely to achieve a significant market share. China and India are some of the fastest-growing markets, while the United States and Germany hold some of the most prominent players in the market.
Top Companies Profiled in the Report Include:
Fresenius Medical Care AG & KGaA, Boston Scientific Corporation, Baxter International Inc., Richard Wolf, Karl Storz SE & Co. KG, Medtronic PLC, Cook Medical Incorporated, Olympus Corporation, C. R. Bard, Inc., and Siemens AG.
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Urological Devices market in these key regions.
Country-wise regional analysis covers:
  • North America
  • US.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK.
  • BENELUX
  • Italy
  • Spain
  • Switzerland
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Rest of LATAM
       Middle East & Africa
  • Saudi Arabia
  • U.A.E.
  • South Africa
  • Turkey
  • Rest of MEA
Additionally, the report consists a detailed analysis of the segmentation of the Urological Devices market based on product types and end-use/application offered in the Urological Devices market.
Devices Type Outlook (Revenue, USD Billion; 2016-2027)
  • Dialysis Devices
  • Laser and Lithotripsy Devices
  • Operating Instruments & Consumable Accessories
  • Stents & Stimulators
  • Others
Sales Channel Outlook (Revenue, USD Billion; 2016-2027)
  • Online Retailing
  • Medical Stores & Brand Outlet
Urological Diseases Outlook (Revenue, USD Billion; 2016-2027)
  • Kidney & Bladder Diseases
  • Cancer and BPH
  • Pelvic Organ Prolapse
  • Others
End-Users Outlook (Revenue, USD Billion; 2016-2027)
  • Hospitals
  • Clinics & Dialysis Centers
  • Ambulatory Surgical Center
  • Others
Read  More Reports –
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.  
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:                       
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
 
 
37 days ago
Unfiled. Edited by Jay Sharma 37 days ago
Aneurysm Clips   Market Manufacturers, Type, Application, Regions and Forecast to 2027
Jay S The global aneurysm clips market is forecast to reach USD 1.74 Billion by 2027, according to a new report by Reports and Data. The procedure of accessing blood vessels directly by performing a craniotomy and positioning an aneurysm clip to cut off blood supply is known as aneurysm clipping.
This procedure has been used for years to treat brain aneurysms and is not only effective and safe but can be performed on all types of aneurysm. It lowers the risk of recurrence in many patients. Rising demand for surgical procedures and integration of highly compatible materials into the clips are expected to influence the growth of the market. Moreover, the availability of biocompatible aneurysm clips in a variety of shapes and sizes for applications in the neurological field is expected to create potential growth prospects of the aneurysm clips market. Further, the adoption of these clips is anticipated to accelerate by increasing access to healthcare facilities globally majorly.
In 2016, Neos Surgery developed plastic clips, which allows post-surgical checkups via Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) scans, which is not possible with a metal clip. The technology was developed through the European Union’s Eureka Eurostars program, which funded R&D with USD 1.23 million.
Top Companies Profiled in the Report Include:
Braun Melsungen AG, Peter LAZIC GmbH, KLS Martin Group, Adeor Medical AG, Rebstock Instruments GmbH, Mizuho America, Stryker Corporation, RauMedic, InoMed, and Codman & Shurtleff, among others.
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
Additionally, the report consists a detailed analysis of the segmentation of the Aneurysm Clips market based on product types and end-use/application offered in the Aneurysm Clips market.
Material Outlook (Revenue, USD Billion; 2016-2027)
  • Titanium Aneurysm Clip
  • Cobalt-Chromium Aneurysm Clip
  • Others
Aneurysm Type Outlook (Revenue, USD Billion; 2016-2027)
  • Abdominal
  • Cerebral
  • Thoracic
  • Peripheral
End-Users Outlook (Revenue, USD Billion; 2016-2027)
  • Hospitals and Cardiac Clinics
  • Specialty Clinics
  • Ambulatory Surgical Centers
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Aneurysm Clips market in these key regions.
Country-wise regional analysis covers:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Read More Reports
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements. 
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:                       
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
 
 
41 days ago
Unfiled. Edited by Jay Sharma 41 days ago
Untitled
 
Jay S The global Pharmaceutical Contract Manufacturing market was valued at USD 82430.9 Million in 2018 and is expected to reach USD 144958.8 million by the year 2026, at a CAGR of 7.2%.
The pharmaceutical industry uses outsourcing services from providers in the form of contract research organizations (CROs) and contract manufacturing organizations (CMOs). Comprehensive single-source provider from drug development through commercial manufacture has emerged in recent years. It is known as contract research and manufacturing services (CRAMS), or contract development and manufacturing organizations (CDMO). Pharmaceutical Contract Manufacturing organizations are a response to the competitive international nature of the pharmaceutical market as well as the increasing demand for outsourced services.
With the increasing demand for generic formulations and biologics, complex manufacturing requirements, and the capital-intensive nature of the business, many pharmaceutical companies have identified the potential profitability in contracting with a CMO (contract manufacturing outsourcing) for both commercial and clinical stage manufacturing. Furthermore, pharmaceutical companies have been directing their priorities towards the core areas of competency, and hence, prefer not to dispense available resources, expertise, and technology on formulating the final dose of medicines. The costs invested in R&D are increasing, and the useful results returned from these processes are becoming scarcer. Many manufacturing companies have realized that moving this part of the business overseas and taking advantage of the still-emerging pharmaceutical markets is an effective method of cutting costs. However, Increasing Lead Time and Logistics Costs and stringent Regulatory Requirements by different nations are expected to hinder the pharmaceutical contract manufacturing market growth
Top Companies Profiled in the Report Include:
Thermo Fisher Scientific Inc. (US), Catalent, Inc. (US), Lonza Group Ltd (Switzerland), Recipharm AB (Sweden), Vetter Pharma International GMBH (Germany), FAMAR Health Care Services (Greece), AbbVie Inc. (US), Aenova Group (Germany), Consort Medical plc (UK), Almac Group (UK), Siegfried Holding AG (Switzerland), Boehringer Ingelheim International GmbH (Germany), and Evonik Industries AG (Germany)..
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Pharmaceutical Contract Manufacturing market in these key regions.
Country-wise regional analysis covers:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Additionally, the report consists a detailed analysis of the segmentation of the Pharmaceutical Contract Manufacturing market based on product types and end-use/application offered in the Pharmaceutical Contract Manufacturing market.
Service Outlook (Revenue in Million USD; 2016–2026)
  • Pharmaceutical Manufacturing Services
  • Pharmaceutical API Manufacturing
  • Pharmaceutical FDF Manufacturing
  • Parenteral/Injectable
  • Tablet
  • Capsule
  • Oral Liquid
  • Other Formulations
  • Biologics Manufacturing Services
  • Biologics API Manufacturing
  • Biologics FDF Manufacturing
  • Drug Development Services
End User Outlook (Revenue in Million USD; 2016–2026)
  • Big Pharma
  • Small & Mid-size Pharma
  • Generic Pharmaceutical Companies
  • Other End Users
Read More Reports
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.  
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:                       
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
 
41 days ago
Unfiled. Edited by Jay Sharma 41 days ago
Untitled
 
Jay S The Global Biochip Market size was valued at USD 11.42 Billion in 2020 and is forecast to reach USD 27.51 Billion, at a CAGR of 11.7% through 2028, according to a new report by Reports and Data. The market growth is driven by increasing application of biochip in proteomics, genomics, and drug discovery, coupled with high investment in R&D.
Biochip technologies have a significant impact on genomic research. Various fields such as drug discovery, gene discovery, medical diagnostics, and toxicological research, are benefitting from the use of biochip technologies. Biochip technology is expensive, and its high cost is associated with the complexity of technology, various resources and extensive R&D that goes in for the product manufacturing. Several research institutes are focusing on enhancing the precision of the product while reducing costs and time.  Rise in R&D investment, government funding and high potential in untapped markets is expected to offer lucrative growth opportunities for the biochip market.
Top Companies Profiled in the Report Include:
BioMrieux S.A., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, HORIBA, Ltd., PerkinElmer, Inc., Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., and Randox Laboratories Ltd., among others.
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Biochip market in these key regions.
Country-wise regional analysis covers:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Additionally, the report consists a detailed analysis of the segmentation of the Biochip  market based on product types and end-use/application offered in the Biochip  market.
Product Outlook (Revenue, USD Billion; 2020-2028)
  • DNA Chip
  • Lab-on-chip
  • Protein Chip
  • Others
Technology Outlook (Revenue, USD Billion; 2020-2028)
  • Microfluidics
  • Microarray
Substrate Materials Outlook (Revenue, USD Billion; 2020-2028)
  • Glass
  • Polymers
  • Silicon
  • Others
Applications Outlook (Revenue, USD Billion; 2020-2028)
  • Genomics
  • Proteomics
  • Drug Discovery and Developments
  • In Vitro Diagnostics
  • Disease Diagnostics
  • Agriculture
End Users Outlook (Revenue, USD Billion; 2020-2028)
  • Pharmaceutical and Biotechnology Company
  • Academic and research institute
  • Hospitals and diagnostic centers
  • Other end users
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:                       
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
 
42 days ago
Unfiled. Edited by Jay Sharma 42 days ago
Jay S The AR/VR in Healthcare Market size is estimated to reach USD 11.63 Billion by 2028, registering a CAGR of 28.3% during the forecast period, according to a new report by Reports and Data. Major factors driving market revenue growth are healthcare digitalization, government initiatives for technological advancement in medicine, increasing healthcare expenditure, and improved medical training.
In 2021, there will be a lot of interest in VR and AR from a variety of industries, including healthcare. More and more healthcare organisations are preparing to upgrade their digital solutions with virtual reality and augmented reality (VR/AR) technologies to improve data analysis and healthcare procedures. Some businesses have discovered new ways to engage with their patients during the pandemic by using these technologies, enabling them to provide remote and individualised care. Others employ AR/VR to enhance medical training or prepare for pre-surgery activities.
VR and AR technology are being used by healthcare companies to improve consumer experiences by effectively engaging customers in healthcare operations. This will drive AR/VR in healthcare market growth in the coming years. For example, healthcare companies and their clients can arrange the sequence of procedures and observe the results using VR apps for cosmetic medicine and orthodontia. Healthcare professionals in the field of ophthalmology can supply their patients with an app that stimulates the eyesight of patients with specific disorders such as cataracts or AMD, among others. Patients will gain a better understanding of the problem and will be more engaged in their treatment.
Growth is predicted to be fueled by lower healthcare costs, fast digitalization, and enhanced delivery of effective health services. Due to extensive adoption in telemedicine, medical training & education, patient care management, and medical marketing during the COVID-19 epidemic, AR/VR in healthcare market  has gained considerable traction in 2020-2021.
The AR/VR in healthcare market is restrained by a lack of expertise in the deployment of AR and VR solutions, as well as a lack of skill among medical practitioners to accept new technology.
Top Companies Profiled in the Report Include:
Microsoft
Google
Mindmaze
DAQRI
Psious
CAE Healthcare
Medical Realities
Atheer
Augmedix
Oculus VR
Firsthand Technology
Siemens Healthineers
Philips Healthcare
3D Systems
VirtaMed
Virtually Better.
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the AR/VR in Healthcare market in these key regions.
Country-wise regional analysis covers:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Additionally, the report consists a detailed analysis of the segmentation of the AR/VR in Healthcare market based on product types and end-use/application offered in the AR/VR in Healthcare market.
Technology Outlook (Revenue, USD Billion; 2020 – 2028)
  • AR
  • VR
Component Outlook (Revenue, USD Billion; 2020 – 2028)
  • Hardware
  • Software
Application Outlook (Revenue, USD Billion; 2020 – 2028)
  • Simulation& diagnostics
  • Surgeries
  • Patient care management
  • Education
End Use Outlook (Revenue, USD Billion; 2020 – 2028)
  • Hospitals & Clinics
  • Surgical centers
  • Research organizations
Read More Reports –
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.  
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:                       
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
 

Contact Support



Please check out our How-to Guide and FAQ first to see if your question is already answered! :)

If you have a feature request, please add it to this pad. Thanks!


Log in / Sign up